Logo for Lineage Cell Therapeutics Inc

Lineage Cell Therapeutics Investor Relations Material

Latest events

Logo for Lineage Cell Therapeutics Inc

Q3 2023

Lineage Cell Therapeutics
Logo for Lineage Cell Therapeutics

Q3 2023

9 Nov, 2023
Logo for Lineage Cell Therapeutics

Q2 2023

10 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from over 8,000 public companies
Lineage Cell Therapeutics, Inc., a biotechnology company, develops cell therapies for the treatment of degenerative diseases. The company develops allogeneic cellular therapies from immortally differentiated human cells. It is developing VAC, an allogeneic cancer immunotherapy for the treatment of solid tumors; OPREGEN, an allogeneic retinal pigment epithelial cell product for the treatment of dry age-related macular degeneration, as well as wet age-related macular degeneration and diabetic eye diseases; Neo-Kidney Augment, an allogeneic product candidate that is in preclinical study to treat subjects with end stage renal disease.